We are committed to providing hope in the face of despair by developing a tumor-targeting drug (SONALA-001) together with MR-guided focused ultrasound as sonodynamic therapy (SDT). This combination has the potential to be a safe and effective noninvasive treatment for cancer.
SonALAsense is the first company to advance SDT into clinical trials.
Soundly Defeating Cancer
SDT is a Platform Technology
SonALAsense is pursuing a Pipeline of additional indications utilizing SDT to treat multiple tumor types.
Our science targets cancer's own needs to cause it to destroy itself.
SDT metabolically targets cancer cells causing immediate and programmed cell death.
Clinical trials now recruiting, Contact Us to learn more about eligibility.